An emerging biopharma lacked cross-functional alignment and structured launch planning. IQVIA applied its Launch Excellence Framework to clarify governance, prioritize critical milestones, and implement change management. Tailored tools enabled coordinated tracking and transparent roles across regional teams. Results included improved risk mitigation, clarified responsibilities, and an integrated evidence strategy. Key success factors identified were: targeting the right therapeutic area, defining a strong value proposition, building external partnerships, and ensuring efficient pre-launch planning despite limited resources.

Join for free to read